Aims & Scope
Aim:
The International Journal of Clinical Investigation and Case Reports (IJCICR) is devoted to providing systematic coverage of the clinical trial and clinical research technique, progress, and outcomes. IJCICR is a peer-reviewed journal that publishes original research quickly and critically examines the most recent breakthroughs in medical research.
Scope:
The International Journal of Clinical Investigation and Case Reports (IJCICR) covers current concerns in clinical drug research and methods, as well as providing a venue for the rapid dissemination of new medication data from human investigations. Coverage includes vaccinations, monoclonal antibodies, antisense, cell, and gene therapies, and recombinant proteins, as well as conventional small-molecule pharmaceuticals and biotech-derived therapeutic entities including vaccines, monoclonal antibodies, antisense, cell, and gene therapies, and recombinant proteins. Overviews of new medications or therapeutic classes in clinical trials, For specific diseases or therapeutic areas, clinical progress is being made. Clinical findings from Phase I to IV studies, pharmacoeconomics and healthcare outcomes Individualized therapy and patient stratification Commentary on ongoing trials, Concerns about drug safety and monitoring of adverse events Clinical trial biomarkers, Regulatory issues, Clinical trial data management, and statistics.
Topics covered include:
|
|
|